Gavi, the Vaccine Alliance appointed the University of Zambia (UNZA) to conduct a process evaluation of Zambia’s national immunisation programme.

The Vaccine Investment Strategy (VIS) enables Gavi to maximise the number of lives it helps save and the number of people whose health it improves, while facilitating long‑term planning for partners, donors, manufacturers and Gavi‑supported…

This analysis paper describes the circumstances in which the Gavi Secretariat took on a broader set of roles and responsibilities in supporting COVID-19 vaccine delivery than originally intended and summarises the nature of those contributions.…

In June 2024, the Gavi Board will be invited to approve the Gavi Secretariat’s framework for its next five-year strategy (“Gavi 6.0”), starting in 2026. Read on to learn more about the process.

Gavi’s role in mitigating global health threats.

Gavi is proud to announce that INFUSE 2024 is actively seeking innovative solutions uniquely positioned to enhance health systems, enabling them to effectively manage resilient and climate-adaptive responses to climate threats.

Request access to Gavi’s Zero-dose resources database.

Drawing upon experiences gained during the COVID-19 pandemic in coordinating the COVAX Strategic Coordination Office (SCO), this paper proposes lessons for future pandemic responses, as well as what might be maintained during intra-pandemic…

A historic multilateral effort co-led by Gavi, CEPI, WHO and UNICEF from 2020 through 2023, COVAX pushed to centre vaccine equity at the heart of the global response to the COVID-19 pandemic. COVAX will come to a close on 31 December 2023.